Member Info for Jet7

A momentous day for all FUM shareholders, very simple now going forward, good sales, FDA approval, patent extension and finally Futura getting on and launching in all jurisdictions around the world as soon as possible. Then we’ve hit the jackpot!

With eleven sites to build and commission, interest rates high, I can only imagine this is causing the rapid drop in the share price. Surely the board will be able to manoeuvre their way through the coming tough times.

Well I can assure you personally that data is wrong

Absolutely not true. Buys are showing up red/sells.

Now an unbelievable 37p difference in share price between TRIG and UKW. Something within the company needs to change here with the share price down like this.

The crux to me here is the major shareholder and shareholders are not selling as far as we know, leading up to phase 3 trial results , Lombard off loaded many millions of shares only to buy back in when they tanked on results. We the share holders are the impatient ones, only literally a couple of weeks into March, yet the company have expressed release in first six months. FDA approval imminent, positive result will lead to the start of the fireworks.

The company got it completely wrong first time round with CSD, now holding all the cards JB said at the AGM that he expected to provide shareholders with good news throughout the coming year. Nearly there, have belief, the company will not mess this up.

Nothing on FUM website other than released in next few months, nothing on Coopers website. All fake news in my opinion. Wait to hear from the horses mouth.

Are you sure, share price now lagging 30/32p behind Greencoat having been virtually at parity 18 months / 2 years ago, plus a 5% rise in the dividend against UKW 13% rise.

I’d suggest the board need to have a hard look at themselves along with the companies advising them. The share price other than a few spikes and lows has remained at this level for far far too long.

I was responsible for a £10.5k buy yesterday, it appeared as a sell.

Take everything with a pinch of salt leading up to FDA approval, so much rubbish on the internet, on this occasion Paperdrunk sums it up pretty well.

Personally I’ll wait until either Coopers, who have not yet even announced it on their site or FUM come out and inform us. I will also be astonished if Eroxon has not been launched in time for Feb 14th, only three weeks away, it would simply have to be the number one buy for the time of year with all the publicity it would surround the first proven product for ED since Viagra.

I go back to a subject I posted on previously, the institutions are undoubtably in command of this company and ultimately Eroxon and not one sell from what we know to date. They now have significant monies invested here, that says a lot.

Static over the last six months will do me just fine, especially when you see some carnage out there. I suspect many investors would love to have trodden water along with the expectations we await in the New Year!

Plus I doubt there are many stocks with the potential of FUM running into 2023, but it’s about time!

No misapplication side effects, simply as I understand, the gel in a phase 2 trial was applied incorrectly (too the wrong area of the *****), this lead to FUM conducting a phase 3 trial at enormous expense. It was doomed from the outset, consequently though Med 3000 was born. Contains no drugs and if reciprocates in real life as it has done in two trials and test run by European partner, I expect this to absolutely fly.

Obviously crucial then that the gel is applied to the glands ***** under the correct environment , otherwise I believe it will not have the desired effect. Seems to me that the instructions are paramount for Med 3000 success.

All very quiet, eight weeks until Christmas so highly unlikely any launch prior, as JB suggested.

So when and where? Could FUM be planning along with their partners for one sensational launch leading up to Valentines Day? Can you imagine magazines and day time TV in overdrive, a new proven over the counter gel with a European kite mark for ED, completely safe for all users. If they do , I believe it will be one fantastic coop along with I suspect plenty of free advertising.

FUM as we know have had plenty of time to put everything in place, perhaps this has been their long term plan. I could honestly see this being a case of out of stock around the various outlets if I’m correct, as demand May outstrip supply.

The key to the success of Eroxon now is I believe something small but absolutely crucial, INSTRUCTIONS ON USE. We know to our expense the implications of when the gel is applied to the wrong area of the *****, along with exactly when to use it is what I’m most keen to see when it becomes available.

If the renewables end up receiving less money for the power they produce, it will inevitably lead to an issue of companies finding it not worth while investing in new infrastructure, which as we speak will be rising rapidly in cost to build.

This country and even continent are becoming a laughing stock.

So Mr Adams has reduced by give or take 1M shares, not bad business. Bought in at I believe 8p a share several years back. Covering his costs I would suggest, with the chance of making many £M’s to come. Very clever.

For me FDA approval and signing of partnership should be the start of the major rise, once the Yanks become aware Im sure the rise will happen on two fronts.

https://au.finance.yahoo.com/news/futura-medical-plc-lon-fum-143710133.html

Institutions have control, stand to make a fortune if Eroxon is successful, still appear not to be selling any stock. Does that tell us something?

Management and advisors here need a kick up the backside, seriously needs to look at how this fund is run!

Looks like the plunge could be down to Keir Starmer announcing that Labour would nationalise green energy.

Do hope that I’m not tempting fate, but there is one subject that stands out for me over this year. Not one the largest shareholders including Lombard have reduced their holding, leading up to the phase 3 trial result back in Dec 2020, Lombard off loaded a considerable amount. In fact Lombard increased by around 2% back in April/May of this year.

I cannot imagine that a company like Lombard are going to sit around if there wasn’t true belief. Without looking I think they hold around 25-27% of FUM. I’m sure like everyone there will be a time to take some profits. But considering the fairly large sells over the last few months I believe this bodes well in the belief and future of Eroxon.